A Randomized, Open-label, Single Dose, 2-treatment, 2-period, 2-way Crossover Study to Assess the Pharmacokinetic Characteristics of YH14659, a Fixed Dose Combination Compared With Coadministration of Separate Constituents Under Fasted Conditions in Healthy Male Subjects
Latest Information Update: 13 Aug 2012
Price :
$35 *
At a glance
- Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
- Indications Coronary disorders; Embolism and thrombosis
- Focus Pharmacokinetics
- 13 Aug 2012 New trial record